Pharming Group N.V. (PHAR) reporting calendar
Pharming Group N.V. files periodic reports with the SEC as PHAR on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 2 Apr 2026
- Reports on record
- 6
Open PHAR market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 2 Apr 2026 | 92 days | 0001828316-26-000015 |
| 20-F | 31 Dec 2024 | 3 Apr 2025 | 93 days | 0001828316-25-000017 |
| 20-F | 31 Dec 2023 | 4 Apr 2024 | 95 days | 0001828316-24-000008 |
| 20-F | 31 Dec 2022 | 5 Apr 2023 | 95 days | 0001628280-23-010793 |
| 20-F | 31 Dec 2021 | 6 Apr 2022 | 96 days | 0001628280-22-008574 |
| 20-F | 31 Dec 2020 | 7 Apr 2021 | 97 days | 0001628280-21-006652 |
Source: SEC EDGAR company submissions for CIK 0001828316. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.